Page breadcrumb nav

VAERS Report 2156692

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fn5254


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-01-22
Date d’apparition
17
Nombre de jours (date d’apparition – date de vaccination)
17
Description de l’événement indésirable

breast tenderness; bleeding; headache; significant mood fluctuations; frequent periods; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from a regulatory authority. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202131713119670-frunr. other case identifier(s): gb-mhra-adr 26621521. a 43 year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 22jan2022 (lot number: fn5254) as dose 3 (booster), single for covid-19 immunisation. the patient had no relevant medical history. concomitant medication(s) included: paracetamol taken for cluster headache, start date: 09feb2022, stop date: 09feb2022. vaccination history included: bnt162b2 (dose 1; batch/lot number unknown), for covid-19 vaccination; bnt162b2 (dose 2; batch/lot number unknown), for covid-19 vaccination. the following information was reported: breast tenderness (medically significant), outcome "recovering", described as "breast tenderness"; haemorrhage (medically significant), outcome "recovering", described as "bleeding"; polymenorrhoea (medically significant) with onset 08feb2022, outcome "recovering", described as "frequent periods"; headache (medically significant), outcome "unknown", described as "headache"; mood swings (medically significant), outcome "unknown", described as "significant mood fluctuations". clinical course: patient last menstrual period date: 31jan2022.text for relevant medical history and concurrent conditions: i do not have any relevant medical history and i do not take regular medication. i perform regular physical exercise and i have a healthy & balanced diet. patient has not had symptoms associated with covid-19.not had a covid-19 test. patient is not pregnant, patient is not currently breastfeeding. main period cycle started 31jan2022 and ended on 05feb2022 (this timeframe if my usual cycle length). new period bleeding started 08feb22 and now on 13feb2022, spotting still exists. the secondary bleeding was accompanied by hormonal changes symptoms such as extreme breast tenderness, headaches and significant mood fluctuations. patient has not tested positive for covid-19 since having the vaccine. patient is not enrolled in clinical trial no follow-up attempts are possible. no further information is expected

Données de laboratoire
na
Liste des symptômes
headache haemorrhage mood swings polymenorrhoea breast tenderness
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na